| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |